BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 16081150)

  • 1. The role of interstitial brachytherapy using template in locally advanced gynecological malignancies.
    Agrawal PP; Singhal SS; Neema JP; Suryanarayan UK; Vyas RK; Rathi AK; Bahadur AK
    Gynecol Oncol; 2005 Oct; 99(1):169-75. PubMed ID: 16081150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective analysis of role of interstitial brachytherapy using template (MUPIT) in locally advanced gynecological malignancies.
    Nandwani PK; Vyas RK; Neema JP; Suryanarayan UK; Bhavsar DC; Jani KR
    J Cancer Res Ther; 2007; 3(2):111-5. PubMed ID: 17998736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose-rate interstitial brachytherapy for gynecologic malignancies.
    Beriwal S; Bhatnagar A; Heron DE; Selvaraj R; Mogus R; Kim H; Gerszten K; Kelley J; Edwards RP
    Brachytherapy; 2006; 5(4):218-22. PubMed ID: 17118313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HDR interstitial perineal implant for locally advanced or recurrent uterine cervix cancer.
    Susworo R; Supriana N; Ramli I
    Radiat Med; 2004; 22(1):2-5. PubMed ID: 15053165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perineal template interstitial brachytherapy salvage for recurrent endometrial adenocarcinoma metastatic to the vagina.
    Nag S; Martínez-Monge R; Copeland LJ; Vacarello L; Lewandowski GS
    Gynecol Oncol; 1997 Jul; 66(1):16-9. PubMed ID: 9234914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
    Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
    Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer.
    Pötter R; Dimopoulos J; Georg P; Lang S; Waldhäusl C; Wachter-Gerstner N; Weitmann H; Reinthaller A; Knocke TH; Wachter S; Kirisits C
    Radiother Oncol; 2007 May; 83(2):148-55. PubMed ID: 17531904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose-rate interstitial brachytherapy with computed tomography-based treatment planning for patients with locally advanced uterine cervical carcinoma.
    Saitoh J; Ohno T; Sakurai H; Katoh H; Wakatsuki M; Noda SE; Suzuki Y; Sibuya K; Takahashi T; Nakano T
    J Radiat Res; 2011; 52(4):490-5. PubMed ID: 21785237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iridium-192 transperineal interstitial brachytherapy for locally advanced or recurrent gynecological malignancies.
    Gupta AK; Vicini FA; Frazier AJ; Barth-Jones DC; Edmundson GK; Mele E; Gustafson GS; Martinez AA
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):1055-60. PubMed ID: 10192355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: clinical feasibility and preliminary results.
    Dimopoulos JC; Kirisits C; Petric P; Georg P; Lang S; Berger D; Pötter R
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):83-90. PubMed ID: 16839702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose-rate interstitial brachytherapy in the management of carcinoma of the uterine cervix and other gynecologic malignancies.
    Sitathanee C; Pairatchvet V; Narkwong L; Puataweepong P
    J Med Assoc Thai; 2005 Aug; 88(8):1045-50. PubMed ID: 16404830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasound-guided interstitial brachytherapy in the treatment of advanced vaginal recurrences from cervical and endometrial carcinoma.
    Weitmann HD; Knocke TH; Waldhäusl C; Pötter R
    Strahlenther Onkol; 2006 Feb; 182(2):86-95. PubMed ID: 16447015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A modified technique for high-dose-rate intracavitary brachytherapy in advanced cancer of the cervix.
    Sharma V; Mahantshetty U; Menon V; Sharma D
    Brachytherapy; 2003; 2(4):246-8. PubMed ID: 15062133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technically accurate intracavitary insertions improve pelvic control and survival among patients with locally advanced carcinoma of the uterine cervix.
    Corn BW; Hanlon AL; Pajak TF; Owen J; Hanks GE
    Gynecol Oncol; 1994 Jun; 53(3):294-300. PubMed ID: 8206401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal management of locally advanced cervical carcinoma.
    Keys H; Gibbons SK
    J Natl Cancer Inst Monogr; 1996; (21):89-92. PubMed ID: 9023835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High dose-rate intracavitary brachytherapy for cervical carcinomas with lower vaginal infiltration.
    Kazumoto T; Kato S; Tabushi K; Kutsutani-Nakamura Y; Mizuno H; Takahashi M; Shiromizu K; Saito Y
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1157-66. PubMed ID: 17459604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
    Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
    Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of severe gastrointestinal toxicity after external beam radiotherapy and interstitial brachytherapy for advanced or recurrent gynecologic malignancies.
    Kasibhatla M; Clough RW; Montana GS; Oleson JR; Light K; Steffey BA; Jones EL
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):398-403. PubMed ID: 16542793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of high-dose rate intracavitary brachytherapy for squamous cell carcinoma of the uterine cervix.
    Nakano T; Kato S; Ohno T; Tsujii H; Sato S; Fukuhisa K; Arai T
    Cancer; 2005 Jan; 103(1):92-101. PubMed ID: 15540233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma.
    Lertsanguansinchai P; Lertbutsayanukul C; Shotelersuk K; Khorprasert C; Rojpornpradit P; Chottetanaprasith T; Srisuthep A; Suriyapee S; Jumpangern C; Tresukosol D; Charoonsantikul C
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1424-31. PubMed ID: 15275728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.